Alterity Therapeutics Ltd.ASX: ATH

Expanded ATH434 Phase 2 Clinical Development Program

Oct 19, 2021 at 2:32 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment